95
Participants
Start Date
August 5, 2014
Primary Completion Date
October 12, 2018
Study Completion Date
January 31, 2022
Satralizumab
Satralizumab will be administered subcutaneously (SC) at Weeks 0, 2, and 4, and thereafter once every 4 weeks (Q4W).
Placebo
Placebo will be administered subcutaneously (SC) at Weeks 0, 2, and 4, and thereafter once every 4 weeks (Q4W).
National Cheng Kung University Hospital; Neurology, Tainan City
Philippine General Hospital, Manila
MHATNP Sveti Naum EAD, Sofia
UMHAT Alexandrovska, EAD, Sofia
Kiev National Medical University, Kiev
Severance Hospital - Yonsei University Health System - Neurology, Seoul
"Municipal Foundation of Kyiv Regional Council Kyiv Region", Kyiv
MMA-MHAT Pleven - Clinic for Neurology, Pleven
UMHAT 'Dr. Georgi Stranski', EAD, Pleven
Medical Help Center EOOD, Dobrich
Taipei Veterans General Hospital-Neurology, Taipei
Hospital Universiti Sains Malaysia [Neurology], Kubang Kerian
Thomas Jefferson University, Philadelphia
Vinnytskyi natsionalnyi medychnyi universytet imeni M.I. Pyr, Vinnytsia
University of North Carolina at Chapel Hill, Chapel Hill
The Neurological Institute PA, Charlotte
Klinicki bolnicki centar Osijek, Osijek
Columbus Research and Wellness, Columbus
The MS Center of Vero Beach, Vero Beach
University of Miami UHealth Professional Arts Center, Miami
Bilim University Medical Faculty Florence Nightingale Hospital, Istanbul
China Medical University Healthcare System, Taichung
OhioHealth Research Institute, Columbus
Reginal clinical psyconeurological hospital, Ternopil
Wayne State University - Comp Clinic and MS. Center, Detroit
Miska Klinichna Likarnia №16, Dnipropetrovsk
Hospital Kuala Lumpur, Kuala Lumpur
Wheaton Franciscan Healthcare - St. Francis Outpatient Center; Center for Neurological Disorders, Milwaukee
Ondokuz Mayis Univ. Med. Fac., Samsun
Consultants in Neurology Ltd, Northbrook
University of Chicago; Neurology, Chicago
OSF Saint Francis Medical Center, Peoria
"KU Odeskyi oblasnyi medychnyi tsentr psykhichnoho zdorovia", Odesa
University of Kansas Medical Center, Kansas City
MidAmerica Neuroscience Institute, Prairie Village
"Municipal Establishment City Clinical Hospital #2; Neurology", Zaporozhya
University of Texas Southwestern Medical Center, Dallas
Ivano-Frankivska oblasna klinichna likarnia, Ivano-Frankivsk
Ivano-Frankivska miska klinichna likarnia №1, Ivano-Frankivsk
UT Medicine San Antonio, San Antonio
Central Texas Neurology Consultants, Round Rock
University of Colorado Denver -; Neurology, Aurora
PO G.Rodolico, AOU Policlinico-Vittorio Emanuele Catania, Catania
SC Clubul Sanatatii SRL, Campulung Muscel
University of Michigan Health System, Ann Arbor
Virginia Commonwealth University, Richmond
MS Clinical Trials Group, Vancouver
Recherche Sepmus Inc., Greenfield Park
Centre hospitalier de l'Universite de Montreal (CHUM), Montreal
LTD Helsicore, Tbilisi
Pineo Medical Ecosystem LTD, Tbilisi
S.Khechinashvili Tbilisi State Medical University Clinic Ne, Tbilisi
NZOZ Wielospecjalistyczna Poradnia Lekarska SYNAPSIS, Katowice
Miedzyleski Szpital Specjalistyczny w Warszawie, Warsaw
San Juan MS Center, Guaynabo
Korea University Anam Hospital - Neurology, Seoul
Seoul National University Hospital, Seoul
Asan Medical Center, Seoul
Collaborators (1)
Chugai Pharmaceutical
INDUSTRY
Hoffmann-La Roche
INDUSTRY